Tu1056 A Phase 3, Double-Blind Study of a Triple Therapy With TAK-438, Amoxicillin, and Clarithromycin As First Line Eradication of H. pylori and a Triple Therapy With TAK-438, Amoxicillin, and Metronidazole As Second Line Eradication of H. pylori

Publication | Closed Access

DOI

Citations

References

2014

Year

Kazunari Murakami, Yuuichi Sakurai, Madoka Shiino, Nobuo Funao, Akira Nishimura, Masahiro Asaka

Gastroenterology

Health SciencesAntibioticsTriple TherapyAntibiotic AdjuvantPharmacologyH. PyloriPharmacotherapyFirst Line EradicationAntimicrobial ChemotherapyMedicineClinical MicrobiologyAntimicrobial ResistanceDrug Resistance